Drug Type Small molecule drug |
Synonyms QuitPak + [4] |
Action antagonists, inhibitors |
Mechanism AChR antagonists(Acetylcholine receptor; alpha1/beta1/delta/gamma antagonists), CYP2D6 inhibitors(Cytochrome P450 2D6 inhibitors), Dopamine reuptake inhibitors + [1] |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC11H21N |
InChIKeyIMYZQPCYWPFTAG-UHFFFAOYSA-N |
CAS Registry60-40-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Smoking Cessation | Phase 2 | United States | - | |
Tobacco Use Disorder | Phase 2 | - | - |